Filing Flows › Retractable Technologies (RVP) › Q3 2025
Retractable Technologies (RVP) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 14, 2025
Retractable Technologies (RVP) reported revenue of $10.1M for the third quarter 2025 (Q3 2025), -3% from a year earlier and -3% from the quarter before. Operating margin was -36.2%, net earnings $371K (3.7% of revenue).
Retractable Technologies, Q3 2025: revenue $10.1M (-2% year over year), operating margin -36.2%, net earnings $371K, operating cash flow −$1.3M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.1M | -3% | -3% |
| Operating profit | −$3.7M | — | — |
| Net earnings | $371K | — | — |
| Operating cash flow | −$1.3M | — | — |
What changed
Revenue was $10.1M in Q3 2025, down 3% year over year and down 3% from the previous quarter. Syringes was the largest line at 58% of revenue. EasyPoint Needles lost $1.0M year over year (down 21%), 387% of the total change.
Gross margin was 16.7%. Operating costs exceeded revenue by $3.7M, an operating margin of -36.2%. The fastest-growing cost line was Research & development (+14%). Net earnings were $371K. The effective tax rate was 0.5%. Non-operating items added $4.0M, 1080% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$1.3M. Non-cash charges added back $1.9M of depreciation and amortization. Working capital and other items used $3.5M. Capital expenditures of $90K exceeded it, leaving free cash flow of −$1.3M.
Questions
What was Retractable Technologies' revenue in the third quarter 2025?
Retractable Technologies (RVP) reported revenue of $10.1M for the third quarter 2025 (Q3 2025), -3% from a year earlier and -3% from the quarter before.
Was Retractable Technologies profitable in the third quarter 2025?
Operating loss was $3.7M (-36.2% of revenue) and net earnings $371K.